These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 8707966)

  • 1. Relationships between bronchiectasis and time to achieving target trough immunoglobulin G levels in patients with common variable immunodeficiency.
    Onalan T; Colkesen F; Kilinc M; Aykan FS; Evcen R; Akkus FA; Ergun UY; Kahraman S; Gerek ME; Arslan S
    Allergy Asthma Proc; 2024 May; 45(3):180-185. PubMed ID: 38755776
    [No Abstract]   [Full Text] [Related]  

  • 2. How I treat common variable immune deficiency.
    Cunningham-Rundles C
    Blood; 2010 Jul; 116(1):7-15. PubMed ID: 20332369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble Interleukin-2 Receptor/White Blood Cell Ratio Reflects Granulomatous Disease Progression in Common Variable Immune Deficiency.
    van Stigt AC; Dalm VASH; Nagtzaam NMA; van Hagen PM; Dik WA; IJspeert H
    J Clin Immunol; 2023 Nov; 43(8):1754-1757. PubMed ID: 37542638
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of dexamethasone on antibody response of horses to vaccination with a combined equine influenza virus and equine herpesvirus-1 vaccine.
    Kreutzfeldt N; Chambers TM; Reedy S; Spann KM; Pusterla N
    J Vet Intern Med; 2024; 38(1):424-430. PubMed ID: 38141173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What Works When Treating Granulomatous Disease in Genetically Undefined CVID? A Systematic Review.
    van Stigt AC; Dik WA; Kamphuis LSJ; Smits BM; van Montfrans JM; van Hagen PM; Dalm VASH; IJspeert H
    Front Immunol; 2020; 11():606389. PubMed ID: 33391274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. International Consensus Document (ICON): Common Variable Immunodeficiency Disorders.
    Bonilla FA; Barlan I; Chapel H; Costa-Carvalho BT; Cunningham-Rundles C; de la Morena MT; Espinosa-Rosales FJ; Hammarström L; Nonoyama S; Quinti I; Routes JM; Tang ML; Warnatz K
    J Allergy Clin Immunol Pract; 2016; 4(1):38-59. PubMed ID: 26563668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Granulomatous disease in CVID: retrospective analysis of clinical characteristics and treatment efficacy in a cohort of 59 patients.
    Boursiquot JN; Gérard L; Malphettes M; Fieschi C; Galicier L; Boutboul D; Borie R; Viallard JF; Soulas-Sprauel P; Berezne A; Jaccard A; Hachulla E; Haroche J; Schleinitz N; Têtu L; Oksenhendler E;
    J Clin Immunol; 2013 Jan; 33(1):84-95. PubMed ID: 22986767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of granulomatous common variable immunodeficiency subsequent to infection with Toxoplasma gondii.
    Mrusek S; Marx A; Kummerle-Deschner J; Tzaribachev N; Enders A; Riede UN; Warnatz K; Dannecker GE; Ehl S
    Clin Exp Immunol; 2004 Sep; 137(3):578-83. PubMed ID: 15320909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-D immunoglobulin treatment for thrombocytopenia associated with primary antibody deficiency.
    Longhurst HJ; O'Grady C; Evans G; De Lord C; Hughes A; Cavenagh J; Helbert MR
    J Clin Pathol; 2002 Jan; 55(1):64-6. PubMed ID: 11825928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common variable immunodeficiency.
    Strober W; Chua K
    Clin Rev Allergy Immunol; 2000 Oct; 19(2):157-81. PubMed ID: 11107500
    [No Abstract]   [Full Text] [Related]  

  • 11. Deficiency in circulating natural killer (NK) cell subsets in common variable immunodeficiency and X-linked agammaglobulinaemia.
    Aspalter RM; Sewell WA; Dolman K; Farrant J; Webster AD
    Clin Exp Immunol; 2000 Sep; 121(3):506-14. PubMed ID: 10971518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fever of unknown origin in a patient with common variable immunodeficiency associated with multisystemic granulomatous disease.
    Fernández-Ruiz M; Guerra-Vales JM; Francisco-Javier CF; Yolanda RG; Miguel-Ingel MG; Cristina GC; Jesús RC
    Intern Med; 2007; 46(15):1197-202. PubMed ID: 17675769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infection outcomes in patients with common variable immunodeficiency disorders: relationship to immunoglobulin therapy over 22 years.
    Lucas M; Lee M; Lortan J; Lopez-Granados E; Misbah S; Chapel H
    J Allergy Clin Immunol; 2010 Jun; 125(6):1354-1360.e4. PubMed ID: 20471071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypercalcemia in a patient with common variable immunodeficiency and renal granulomas.
    Meyer A; Lachmann HJ; Webster AD; Burns A; Thway K
    Am J Kidney Dis; 2005 May; 45(5):e90-3. PubMed ID: 15861342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic strategies in common variable immunodeficiency.
    Sewell WA; Buckland M; Jolles SR
    Drugs; 2003; 63(13):1359-71. PubMed ID: 12825961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous gamma globulin administration to common variable immunodeficient women during pregnancy: case report and review of the literature.
    Schaffer FM; Newton JA
    J Perinatol; 1994; 14(2):114-7. PubMed ID: 8014693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Granulomatous disease in common variable immunodeficiency: effect on immunoglobulin replacement therapy and response to steroids and splenectomy.
    Spickett GP; Zhang JG; Green T; Shrimankar J
    J Clin Pathol; 1996 May; 49(5):431-4. PubMed ID: 8707966
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.